Cyclosporine enhances the expression of TGF-beta in the juxtaglomerular cells of the rat kidney.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Kidney International

• Publication date

  1995-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/KI.1995.438PMID 8544405
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Localization of PDGF-BB in the juxtaglomerular cells of cyclosporin-treated rats.

  1995cited by this paper
• Transforming growth factor-beta in glomerular injury.

  1994cited by this paper
• Regulation of new DNA synthesis in mammalian cells by cyclosporine. Demonstration of a transforming growth factor beta-dependent mechanism of inhibition of cell growth.

  1994cited by this paper
• Increased platelet-derived growth factor in the kidneys of cyclosporin-treated rats.

  1994cited by this paper
• Expression of transforming growth factor beta 3 in hypertrophic juxtaglomerular apparatus.

  1994cited by this paper
• Transforming growth factor-beta protein and mRNA in glomeruli in normal and diseased human kidneys.

  1993cited by this paper
• Blockade of endothelium-dependent responses in conscious rats by cyclosporin A: effect of L-arginine.

  1993cited by this paper
• Genomic sequencing.

  1993cited by this paper
• Renal vascular induction of TGF-beta 2 and renin by potassium depletion.

  1993cited by this paper
• Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney.

  1993cited by this paper
• Renal vascular induction of TGF-β2 and renin by potassium depletion

  1993cited by this paper
• Arginine feeding modifies cyclosporine nephrotoxicity in rats.

  1993cited by this paper
• Acute cyclosporine-induced renal vasoconstriction is mediated by endothelin-1.

  1993cited by this paper
• Renal transplantation in the cyclosporine era.

  1993cited by this paper
• Transforming growth factor-beta is a renin secretagogue at picomolar concentrations.

  1993cited by this paper
• Effects of thromboxane synthase inhibition with CGS 13080 in human cyclosporine nephrotoxicity.

  1992cited by this paper
• Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease

  1992cited by this paper
• Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II.

  1992cited by this paper
• Angiotensin II-induced mitogenesis of spontaneously hypertensive rat-derived cultured smooth muscle cells is dependent on autocrine production of transforming growth factor-beta.

  1992cited by this paper
• Thromboxane receptor blockade attenuates chronic cyclosporine nephrotoxicity and improves survival in rats with renal isograft.

  1992cited by this paper
• Embryonic gene expression patterns of TGF beta 1, beta 2 and beta 3 suggest different developmental functions in vivo.

  1991cited by this paper
• Differential regulation of transforming growth factor beta and interleukin 2 genes in human T cells: demonstration by usage of novel competitor DNA constructs in the quantitative polymerase chain reaction

  1991cited by this paper
• Water deprivation stimulates transforming growth factor-beta 2 accumulation in the juxtaglomerular apparatus of mouse kidney.

  1991cited by this paper
• Cyclosporine-induced chronic nephropathy: an obliterative microvascular renal injury.

  1991cited by this paper
• Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix.

  1990cited by this paper
• Role of endothelin in cyclosporine-induced glomerular dysfunction.

  1990cited by this paper
• Endothelin mediates the renal vasoconstriction induced by cyclosporine in the rat.

  1990cited by this paper
• Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1

  1990cited by this paper
• Cyclosporine.

  1989cited by this paper
• Murine transforming growth factor-beta 2 cDNA sequence and expression in adult tissues and embryos.

  1989cited by this paper
• What is cyclosporine nephrotoxicity?

  1989cited by this paper
• Drug therapy: cyclosporine

  1989cited by this paper
• Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

  1988cited by this paper
• The long-term course of cyclosporine-associated chronic nephropathy.

  1988cited by this paper
• Cyclosporin in cadaveric renal transplantation: 5-year follow-up of a multicentre trial.

  1987cited by this paper
• Glomerular hemodynamics and hormonal participation on cyclosporine nephrotoxicity.

  1987cited by this paper
• EVIDENCE THAT RENAL PROSTAGLANDIN AND THROMBOXANE PRODUCTION IS STIMULATED IN CHRONIC CYCLOSPORINE NEPHROTOXICITY

  1987cited by this paper
• Acute cyclosporine A nephrotoxicity in rats: which role for renin-angiotensin system and glomerular prostaglandins?

  1986cited by this paper
• Beneficial effects of renal denervation and prazosin on GFR and renal blood flow after cyclosporine in rats.

  1986cited by this paper
• Post‐embedding cytochemistry with gold‐labelled reagents: a review

  1986cited by this paper
• Cyclosporine nephrotoxicity.

  1986cited by this paper
• The murine transforming growth factor-beta precursor.

  1986cited by this paper
• A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation

  1986cited by this paper
• Immunolocalization of the gamma isoform of nonmuscle actin in cultured cells

  1986cited by this paper
• Cyclosporine nephrotoxicity: studies in laboratory animals.

  1985cited by this paper
• Effect of cyclosporine administration on renal hemodynamics in conscious rats.

  1985cited by this paper
• Genomic sequencing.

  1984cited by this paper
• Metaplasia of smooth muscle cells into juxtaglomerular cells in the juxtaglomerular apparatus, arteries, and arterioles of the ischemic (endocrine) kidney. An ultrastructural-cytochemical and autoradiographic study.

  1977cited by this paper
• OBSERVATIONS ON THE SIMILARITY OF MESANGIAL TO JUXTAGLOMERULAR CELLS.

  1963cited by this paper
• OBSERVATIONS ON THE SIMILARITY OF MESANGIAL TO JUXTAGLOMERULAR CELLS.

  1963cited by this paper
• Diseases of the lungs.

  1948cited by this paper

• Melanoma risk during immunomodulating treatment

  2022cites this paper
• The Role of Stem Cells Derived From the Mesenchyme of the Umbilical Cord in Reducing Immunosuppressive Drug Doses Used in Allogenic Transplantations

  2022cites this paper
• 2-Methoxyestradiol TPGS Micelles Attenuate Cyclosporine A-Induced Nephrotoxicity in Rats through Inhibition of TGF-β1 and p-ERK1/2 Axis

  2022cites this paper
• Chrysin Ameliorates Cyclosporine-A-Induced Renal Fibrosis by Inhibiting TGF-β1-Induced Epithelial–Mesenchymal Transition

  2021cites this paper
• Rupatadine, a dual antagonist of histamine and platelet-activating factor (PAF), attenuates experimentally induced diabetic nephropathy in rats

  2020cites this paper
• Gene networking in colistin-induced nephrotoxicity reveals an adverse outcome pathway triggered by proteotoxic stress

  2019cites this paper
• Possible Underlying Mechanisms of the Renoprotective Effect of Remote Limb Ischemic Preconditioning Against Renal Ischemia/Reperfusion Injury: A Role of Osteopontin, Transforming Growth Factor-Beta and Survivin

  2016cites this paper
• Renal Allograft Fibrosis: Biology and Therapeutic Targets

  2015cites this paper
• بررسی اثر سیکلوسپورین بر میزان آنتیبادیهای نامتقارن و سایتوکین TGF-β1 در مدل موشی سقط CBA/J×DBA/2

  2015cites this paper
• The effect of cyclosporine on asymmetric antibodies and serum transforming growth factor beta1 in abortion-prone model of mice CBA/J x DBA/2

  2015cites this paper
• Increased and correlated expression of connective tissue growth factor and transforming growth factor beta 1 in surgically removed periodontal tissues with chronic periodontitis.

  2015influential citation
• The role of peroxisome-proliferator-activating receptor gamma agonists: rosiglitazone and 15-deoxy-delta12,14-prostaglandin J2 in chronic experimental cyclosporine A-induced nephrotoxicity.

  2014cites this paper
• Small Animal Models of Transplantation

  2014cites this paper
• FK506 inhibits the mice glomerular mesangial cells proliferation by affecting the transforming growth factor-β and Smads signal pathways

  2014cites this paper
• The Possible Potential Therapeutic Targets for Drug Induced Gingival Overgrowth

  2013cites this paper
• Ultrastructural Examination of Renal Tubular Epithelial Cells and Hepatocytes in the Course of Chronic Cyclosporin A Treatment—A Possible Link to Oxidative Stress

  2013cites this paper
• Green Tea Polyphenols Stimulate Mitochondrial Biogenesis and Improve Renal Function after Chronic Cyclosporin A Treatment in Rats

  2013cites this paper
• Cellular Mechanisms of Drug Nephrotoxicity

  2013cites this paper
• The Impact of CYP3A5 Variation and Pregnancy on the Metabolic Disposition of Calcineurin Inhibitors

  2012cites this paper
• Molecular events associated with ciclosporin A-induced gingival overgrowth are attenuated by Smad7 overexpression in fibroblasts.

  2012cites this paper
• Cyclosporine: A Review

  2012cites this paper
• Gingival fibroblast response to cyclosporin A and transforming growth factor β1

  2010cites this paper
• Expression of transforming growth factor-beta and determination of apoptotic index in histopathological sections for assessment of the effects of Apigenin (4', 5', 7'- Trihydroxyflavone) on Cyclosporine A induced renal damage.

  2009cites this paper
• Chapter 88 – Diagnosis and Management of Renal Allograft Dysfunction

  2008cites this paper
• An underlying role for hepatobiliary dysfunction in cyclosporine A nephrotoxicity.

  2008cites this paper
• Five-Year Study of Tacrolimus as Secondary Intervention Versus Continuation of Cyclosporine in Renal Transplant Patients at Risk for Chronic Renal Allograft Failure

  2008cites this paper
• CHAPTER 87 – Cellular Mechanisms of Drug Nephrotoxicity

  2008cites this paper
• Effects of spironolactone in an experimental model of chronic cyclosporine nephrotoxicity.

  2008cites this paper
• The effects of different immunosuppressants on chronic allograft nephropathy by affecting the transforming growth factor-beta and Smads signal pathways.

  2006cites this paper
• Mycophenolate mofetil impairs the integrity of colonic anastomosis.

  2006cites this paper
• Cytomegalovirus in the process of chronic allograft nephropathy

  2006cites this paper
• Valsartan-induced hematocrit changes in renal transplant patients.

  2005cites this paper
• Nephrotoxicity of immunosuppressant drugs in salt-depletion and modification of effect by an antifibrotic agent

  2005cites this paper
• Prednisolone suppresses cyclosporin A-induced apoptosis but not cell cycle arrest in MDCK cells.

  2005cites this paper
• Immunohistochemical study of cyclosporin-induced gingival overgrowth in renal transplant recipients.

  2004cites this paper
• Plasma TGF-beta1 as a risk factor for gingival overgrowth.

  2004cites this paper
• Cyclosporine A sensitizes the kidney to tubulointerstitial fibrosis induced by renal warm ischemia

  2004cites this paper
• Contribution to the understanding of nephrotoxic mechanisms

  2003cites this paper
• Renal cell culture models: Contribution to the understanding of nephrotoxic mechanisms

  2003cites this paper
• Cyclosporin A induces proliferation in human gingival fibroblasts via induction of transforming growth factor-beta1.

  2003cites this paper
• Platelet-derived growth factor in acute and chronic renal allograft rejection

  2003cites this paper
• Mycophenolate Mofetil Ameliorates Arteriolopathy and Decreases Transforming Growth Factor‐β1 in Chronic Cyclosporine Nephrotoxicity

  2003cites this paper
• Expression of TGF-beta and fibrogenic genes in transplant recipients with tacrolimus and cyclosporine nephrotoxicity.

  2002cites this paper
• A shift in the Bax/Bcl-2 balance may activate caspase-3 and modulate apoptosis in experimental glomerulonephritis.

  2002cites this paper
• The effect of acute rejection and cyclosporin A—treatment on induction of platelet-derived growth factor and its receptors during the development of chronic rat renal allograft rejection1

  2002cites this paper
• Open randomized trial comparing early withdrawal of either cyclosporine or mycophenolate mofetil in stable renal transplant recipients initially treated with a triple drug regimen.

  2002cites this paper
• Opposite effects of testosterone and estrogens on chronic allograft nephropathy

  2002cites this paper
• Molecular and structural consequences of early renal allograft injury.

  2002cites this paper
• Expression of matrix metalloproteinases in cyclosporin-treated gingival fibroblasts is regulated by transforming growth factor (TGF)-beta1 autocrine stimulation.

  2002cites this paper
• Expression of Matrix Metalloproteinases in Cyclosporin-Treated Gingival Fibroblasts Is Regulated by Transforming Growth Factor (TGF)-β1 Autocrine Stimulation

  2002cites this paper
• Apoptosis and caspase-3 in experimental anti-glomerular basement membrane nephritis.

  2001cites this paper
• Caspase-3 and apoptosis in experimental chronic renal scarring.

  2001cites this paper
• Expresión del "Transforming Growt Factor"(TGF)?1 en el síndrome de isquemia-reperfusión en un modelo de trasplante experimental a corazón parado en cerdo.

  2001cites this paper
• The influence of transforming growth factor-beta1 gene polymorphisms on the severity of gingival overgrowth associated with concomitant use of cyclosporin A and a calcium channel blocker.

  2001cites this paper
• Expression of apoptosis-related genes and proteins in experimental chronic renal scarring.

  2001cites this paper
• Chronic graft dysfunction: donor factors.

  2001cites this paper
• In Vitro and In Vivo Transfection of p21 Gene Enhances Cyclosporin A-Mediated Inhibition of Lymphocyte Proliferation

  2000cites this paper
• The calcium channel blocker used with cyclosporin has an effect on gingival overgrowth.

  2000cites this paper
• Assessment of immunosuppressant drug carcinogenicity: standard and alternative animal models

  2000cites this paper
• Characterization of a DNA binding site that mediates the stimulatory effect of cyclosporin-A on type III collagen expression in renal cells.

  2000cites this paper
• CyA-Mediated Renal Interstitial and Vascular Lesions in the Rat under Low-Sodium Diet

  2000cites this paper
• Individual or combined effects of enalapril and verapamil on chronic cyclosporine nephrotoxicity in rats.

  1999cites this paper
• The role of transforming growth factor-beta in transplant rejection.

  1999cites this paper
• Transforming growth factor (TGF)-beta mimics and anti-TGF-beta antibody abrogates the in vivo effects of cyclosporine: demonstration of a direct role of TGF-beta in immunosuppression and nephrotoxicity of cyclosporine.

  1999cites this paper
• Cyclosporine-induced interstitial fibrosis and arteriolar TGF-beta expression with preserved renal blood flow.

  1999cites this paper
• Transforming growth factor-beta levels in human allograft chronic fibrosis correlate with rate of decline in renal function.

  1999cites this paper
• The role of transforming growth factor-β in transplant rejection

  1999cites this paper
• Cyclosporine induces the expression of the cyclin inhibitor p21.

  1999cites this paper
• Pentosan polysulfate treatment reduces cyclosporine-induced nephropathy in salt-depleted rats.

  1999cites this paper
• Tacrolimus induces increased expression of transforming growth factor-beta1 in mammalian lymphoid as well as nonlymphoid cells.

  1999cites this paper
• Cyclosporine arteriolopathy: effects of drug withdrawal.

  1998cites this paper
• Captopril prevents nephropathy in HIV-transgenic mice.

  1998cites this paper
• Gingival fibroblast response to cyclosporin A and transforming growth factor beta 1.

  1998cites this paper
• Link between angiotensin II and TGF-beta in the kidney.

  1998cites this paper
• Molecular mechanisms of angiotensin II in the kidney: emerging role in the progression of renal disease: beyond haemodynamics.

  1998cites this paper
• Renal expression of transforming growth factor-β inducible gene-h3 (βig-h3) in normal and diabetic rats1

  1998cites this paper
• TGF-β: A Link Between Immunosuppression, Nephrotoxicity, and CsA

  1998cites this paper
• Link between Angiotensin II and TGF-β in the Kidney

  1998cites this paper
• Vascular endothelin, TGF-beta, and PDGF expression in FK506 nephrotoxicity of rats.

  1998cites this paper
• Renal expression of transforming growth factor-beta inducible gene-h3 (beta ig-h3) in normal and diabetic rats.

  1998cites this paper
• TGF-beta: a link between immunosuppression, nephrotoxicity, and CsA.

  1998cites this paper
• An endothelin-transforming growth factor beta pathway in the nephrotoxicity of immunosuppressive drugs.

  1998cites this paper
• Potential interest of anti-ischemic agents for limiting cyclosporin A nephrotoxicity.

  1997cites this paper
• [Mediators involved in the nephrotoxicity of cyclosporin A].

  1997cites this paper
• Angiotensin II blockade decreases TGF-beta1 and matrix proteins in cyclosporine nephropathy.

  1997cites this paper
• Mechanism of fibrosis in experimental tacrolimus nephrotoxicity.

  1997cites this paper
• Nephrotoxicity of immunosuppressive drugs: experimental and clinical observations.

  1997cites this paper
• Immunological mechanism of chronic rejection

  1997cites this paper
• Enhancement of chronic cyclosporine nephrotoxicity by sodium depletion in an experimental mouse model

  1997cites this paper
• Acute rejection of renal allografts: mechanistic insights and therapeutic options.

  1997cites this paper
• Sodium depletion enhances fibrosis and the expression of TGF-beta1 and matrix proteins in experimental chronic cyclosporine nephropathy.

  1997cites this paper
• Drug nephrotoxicity: an overview.

  1997cites this paper
• Role of the transforming growth factor and monocyte chemoattractant protein in FK506-induced nephropathy in the rat.

  1997cites this paper
• Cyclosporine nephropathy: pathophysiology and clinical impact.

  1996cites this paper
• Increased renal tubular expression of transforming growth factor beta in human allografts correlates with cyclosporine toxicity.

  1996cites this paper
• Growth factor transcripts in rat renal transplants.

  1996cites this paper
• Chronic cyclosporine nephropathy: the Achilles' heel of immunosuppressive therapy.

  1996cites this paper
• Synergistic effects of cyclosporine and rapamycin in a chronic nephrotoxicity model.

  1996cites this paper
• Inhibition of Lymphocyte Proliferation Gene Enhances Cyclosporin A-mediated in Vitro and in Vivo Transfection of P21

  year unknowncites this paper